Skip to main content
Caplight Logo









Dianosic

Dianosic

Private
StrasbourgHealthcare & Life Scienceshttps://www.dianosic.com/

Last Round

Series A

Nov 3, 2025

Total Funding Raised

$1.63M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Dianosic is a medical technology company that develops innovative intranasal drug-delivery solutions and medical devices for the treatment of ENT conditions such as chronic rhinitis, sinusitis, and epistaxis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

medical devicenasal implantchronic rhinosinusitisdrug-eluting implantENT surgerybio-resorbable implantsinus surgerymedtechintranasal balloonsinus patencybiotechear nose and throatENTdrug delivery system

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dianosic Comparables

Compare Dianosic with similar companies based on industry and business-model similarity.

Dianosic comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
S.T. Stent
84%
Medtronic
82%
Lyra Therapeutics
77%

Dianosic Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series ANov 3, 2025
VC RoundFeb 6, 2023
SeedApr 14, 2020

Key People

Founding team and executive leadership

Philippe BASTIDE

CEO

Executive Team

Dianosic Investors

Notable investors and investment history

Dianosic investors
InvestorRounds
Fondation ForceVC Round
NoshaqSeries A
Caisse d'Epargne Grand-Est EuropeSeed
Finovam GestionSeries A
Capital Grand EstSeries A
Région Grand EstSeed
WiSeedVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 337% MoM, reaching 568.

  • Nov 3, 2025

    Raised $8M led by AptarGroup

Dianosic Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Dianosic Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Dianosic's valuation, stock price, and market status.

Firmographic Details

HeadquartersStrasbourg
Employee Range14
Year Founded2017
Last FundingNov 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?